Enterome vs ImmunoScape
Enterome vs ImmunoScape, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and ImmunoScape on 58/100.
Where each one leads
Enterome
- domain rating: 46/100 against 28/100
- funding raised: $124M against $49.7M
- LinkedIn following: 16,846 against 4,364
ImmunoScape
- agent readiness: 39/100 against 21/100
At a glance
| Measure | Enterome | ImmunoScape |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing novel immunotherapies and diagnostics for cancer. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Cancer, Immunotherapy, Diagnostics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 2012 | 2017 |
| Headquarters | Paris, France | Singapore, Singapore |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | ImmunoScape |
|---|---|---|
| Employees | 33 | Not published |
| Total funding | $124M | $49.7M |
| Latest round | Later Stage VC | Series B2 |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 16,846 | 4,364 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | ImmunoScape |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 58/100 |
| Traction | 55/100 | 38/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 34/100 | 23/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | ImmunoScape |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Segment | Google Tag Manager |
What users say
| Measure | Enterome | ImmunoScape |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
Enterome vs ImmunoScape: common questions
Which is better, Enterome or ImmunoScape?
On our 0-100 score Enterome rates higher (60/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Enterome and ImmunoScape compare on the numbers?
Enterome leads on domain rating (46/100 against 28/100), funding raised ($124M against $49.7M), LinkedIn following (16,846 against 4,364). ImmunoScape leads on agent readiness (39/100 against 21/100).
What do real users say about Enterome and ImmunoScape?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full Enterome review and pricing or the ImmunoScape review and pricing. You can also browse other Enterome alternatives we track.